Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
Protracted Treponema pallidum-induced cutaneous chancres in rabbits infected with human T-cell leukemia virus type I.
AIDS Res Hum Retroviruses. 1991 Mar;7(3):323-31. Unique Identifier : AIDSLINE MED/91291503 Tseng CT; Sell S; Department of Pathology and Laboratory Medicine, University of; Texas Medical School, Houston 77225.
Abstract:
In a preliminary study, two of four rabbits infected with human T-cell leukemia virus type I (HTLV-I) demonstrated prolonged primary chancres following superinfection with Treponema pallidum, the causative agent of syphilis. Two rabbits inoculated with 1 x 10(7) HTLV-I-infected human MT-2 cells and two with infected rabbit cells from a line established in this laboratory (RLT-P), developed latent HTLV-I infection as detected by seroconversion 10 weeks after infection and by detection of HTLV-I sequences in the DNA of peripheral blood lymphocytes after amplification by polymerase chair reaction (PCR) 15 weeks after infection. The rabbits remained clinically normal and had normal blood counts. Six months after infection, the four HTLV-infected rabbits and two noninfected controls were challenged by the intradermal inoculation of 1 x 10(6) Treponema pallidum into eight sites on the shaved back. The lesions of two of the HTLV-I-infected rabbits had a time course similar to non-HTLV-I-infected controls and were completely healed by 4 weeks. The lesions of one of the other two rabbits with progressive disease began to heal about 7 weeks after T. pallidum challenge. The cutaneous lesions in the other rabbit remained dark-field positive and became a confluent eschar at 8 weeks; healing only after treatment with penicillin. Four months after the primary challenge none of the six rabbits previously challenged with T. pallidum had developed lesions after rechallenge and thus expressed chancre immunity. These results demonstrate that rabbits with latent HTLV-I infections may have defective cell-mediated immunity.
Keywords: Animal Cell Line Chancre/*COMPLICATIONS/IMMUNOLOGY Concanavalin A/IMMUNOLOGY DNA, Viral/ANALYSIS Human HTLV-I/GENETICS HTLV-I Infections/*COMPLICATIONS/IMMUNOLOGY/MICROBIOLOGY Interleukin-2/BIOSYNTHESIS Lymphocyte Transformation/IMMUNOLOGY Male Polymerase Chain Reaction Rabbits Superinfection/*IMMUNOLOGY Support, Non-U.S. Gov't Syphilis, Cutaneous/*COMPLICATIONS/IMMUNOLOGY JOURNAL ARTICLE 911030
M91A0704
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.